Humanized anti-EphB4 antibodies for the treatment of carcinomas and vasculogenesis-related diseases.
about
Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeastGenomics of squamous cell lung cancerEph receptors and ephrins in cancer: bidirectional signalling and beyond.Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody.
P2860
Humanized anti-EphB4 antibodies for the treatment of carcinomas and vasculogenesis-related diseases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@en
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@nl
type
label
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@en
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@nl
prefLabel
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@en
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@nl
P2093
P2860
P1476
Humanized anti-EphB4 antibodie ...... sculogenesis-related diseases.
@en
P2093
Huajun Jin
Qijun Qian
Zenghui Xu
P2860
P304
P356
10.1517/13543770902835525
P407
P577
2009-07-01T00:00:00Z